Company Search:
Advanced Search
Sponsored Links
LG Life Sciences Ltd Company Snapshot
LG Life Sciences Ltd operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares LG Life Sciences Ltd with three other pharmaceutical manufacturers in Asia: Yifan Pharmaceutical Co Ltd of China (2015 sales of 2.43 billion Chinese Renmimbi [US$361.21 million] of which 68% was Health Products - Medicine), Biocon Limited of India (30.90 billion Indian Rupees [US$463.16 million] of which 73% was Pharma), and Shanghai Raas Blood Products Company Limited which is based in China (2.01 billion Chinese Renmimbi [US$298.68 million] of which 97% was Blood products production and sales).

Sales Analysis. LG Life Sciences Ltd reported sales of 450.53 billion Korean Won (US$400.52 million) for the year ending December of 2015. This represents an increase of 5.9% versus 2014, when the company's sales were 425.60 billion Korean Won. Sales at LG Life Sciences Ltd have increased during each of the previous five years (and since 2010, sales have increased a total of 35%). Sales of Veterinary Pharmaceutical Products saw an increase of 9.0% in 2015, from 356.47 billion Korean Won to 388.43 billion Korean Won. Not all segments of LG Life Sciences Ltd experienced an increase in sales in 2015: sales of Precision Chemical Segment fell 10.2% to 62.10 billion Korean Won.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
LG Life Sciences Ltd
  Stock Performance Chart for LG Life Sciences Ltd
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 59,400
(Figures in Korean Won)
1 Week 0.0%   13 Weeks -10.0%  
4 Weeks -16.5%   52 Weeks -0.2%  
LG Life Sciences Ltd Key Data:
  Ticker: 068870 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 450,526,355,034
(Year Ending Jan 2016).
Employees: 1,367
  Currency: Korean Won Market Cap: 984,672,433,800
  Fiscal Yr Ends: December Shares Outstanding: 16,576,977
  Share Type: Common Closely Held Shares: 5,138,210
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.